23andMe Bankruptcy Issues

Order byBest matchMost fresh

Regeneron To Buy 23andMe For $256M After Bankruptcy

Regeneron To Acquire 23andMe In Bankruptcy Sale, Sparking Data Privacy Concerns

Pharmaceutical giant Regeneron has emerged as the winning bidder for consumer genetics company 23andMe in a court-supervised bankruptcy sale, securing control of a vast database containing the genetic information of over 15 million individuals.

Tampa Free Press on MSN · 10h

· 15h · on MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

· 15h · on MSN

Regeneron to buy 23andMe out of bankruptcy for $256 million

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

· 11h

· 12h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

· 17h

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Hoodline8h

Regeneron Acquires Bankrupt 23andMe's Assets for $256 Million Amidst Potential Layoffs in San Francisco

Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the company faces layoffs and office closure due to financial struggles and a past cyberattack.

Rolling Out14h

The fall of 23andMe and what it means for your DNA

The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

10d

OK AG Drummond issues consumer alert for 23andMe customers

Oklahoma Attorney General Gentner Drummond issued a consumer alert for concerned 23andMe customers after the genetic testing company filed for bankruptcy protection last month.

Yahoo Finance8d

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14

The bankruptcy follows a tumultuous 18 months for 23andMe, marked by declining sales ... grievances unrelated to the cyberattack, such as issues with DNA test results or the company's telehealth ...